BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8938062)

  • 1. Maternal serum inhibin-A levels in twin pregnancies: implications for screening for Down's syndrome.
    Watt HC; Wald NJ; George L
    Prenat Diagn; 1996 Oct; 16(10):927-9. PubMed ID: 8938062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal serum inhibin-A in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome.
    Wald NJ; Watt HC; George L
    Prenat Diagn; 1996 Oct; 16(10):923-6. PubMed ID: 8938061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
    Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
    Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
    Wald NJ; Watt HC
    Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
    Wald N; Cuckle H; Wu TS; George L
    Br J Obstet Gynaecol; 1991 Sep; 98(9):905-8. PubMed ID: 1716981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.
    Cuckle HS; Holding S; Jones R; Groome NP; Wallace EM
    Prenat Diagn; 1996 Dec; 16(12):1095-100. PubMed ID: 8994244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum free alpha-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
    Wald NJ; Densem JW
    Prenat Diagn; 1994 Aug; 14(8):717-9. PubMed ID: 7527538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
    Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
    Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midtrimester maternal serum inhibin A levels after multifetal pregnancy reduction.
    Chen HJ; Huang LW; Lin YH; Seow KM; Hsieh BC; Hwang JL; Tzeng CR
    Prenat Diagn; 2007 May; 27(5):431-4. PubMed ID: 17295349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-trimester dimeric inhibin-A in Down's syndrome screening.
    Spencer K; Wallace EM; Ritoe S
    Prenat Diagn; 1996 Dec; 16(12):1101-10. PubMed ID: 8994245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple marker screening for Down syndrome in twin pregnancies.
    Neveux LM; Palomaki GE; Knight GJ; Haddow JE
    Prenat Diagn; 1996 Jan; 16(1):29-34. PubMed ID: 8821849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
    J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal midtrimester serum AFP and free beta-hCG levels in in vitro fertilization twin pregnancies.
    Räty R; Virtanen A; Koskinen P; Laitinen P; Forsström J; Salonen R; Mörsky P; Ekblad U
    Prenat Diagn; 2000 Mar; 20(3):221-3. PubMed ID: 10719325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal serum inhibin levels in second-trimester Down's syndrome pregnancies.
    Cuckle HS; Holding S; Jones R
    Prenat Diagn; 1994 May; 14(5):387-90. PubMed ID: 7521963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
    Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
    Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies.
    Frishman GN; Canick JA; Hogan JW; Hackett RJ; Kellner LH; Saller DN
    Obstet Gynecol; 1997 Jul; 90(1):98-101. PubMed ID: 9207822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester.
    Christiansen M; Nørgaard-Pedersen B
    Clin Genet; 2005 Jul; 68(1):35-9. PubMed ID: 15952984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus.
    Huttly W; Rudnicka A; Wald NJ
    Prenat Diagn; 2004 Oct; 24(10):804-7. PubMed ID: 15503275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimeric inhibin A as a fourth marker for Down's syndrome maternal serum screening in native Japanese women.
    Yoshida K; Kuwabara Y; Tanaka T; Onda T; Kudo R; Yamamoto H; Sato A; Yanagida K; Okai T; Sakai M; Takai Y; Uemura H; Hoshi K; Fukada Y; Aono T; Maeda K; Ogita S; Ishiko O; Murata Y; Kanzaki T; Myrick F; Grier RE
    J Obstet Gynaecol Res; 2000 Jun; 26(3):171-4. PubMed ID: 10932977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.